The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis
- 1 November 1987
- journal article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 336 (5), 502-507
- https://doi.org/10.1007/bf00169306
Abstract
The effect of TTX (infused during brain dialysis of the striatum and nucleus accumbens) on the in vivo release of dopamine, 3,4-dihydroxyphenylacetic acid and homovanillic acid, was investigated. In addition it was studied whether the increase in the release of dopamine, induced by various pharmacological treatments, was sensitive to TTX infusion. The following drugs were studied: haloperidol, amphetamine, haloperidol co-administered with GBR 12909, morphine and MPP+. Dialysis was carried out in the striatum, except for morphine, which was studied in the nucleus accumbens. The infusion of TTX revealed three different types of pharmacologically enhanced dopamine release in conscious rats. First, action potential dependent dopamine release (exocytosis), which was observed in untreated animals as well as in animals treated with haloperidol, haloperidol + GBR 12909, and morphine. Second, action potential independent release (carrier-mediated) was established in the case of amphetamine. Third, action potential independent DA release, probably caused by neurotoxic reactions was observed during MPP+ infusion.This publication has 21 references indexed in Scilit:
- The use of in vivo brain dialysis of dopamine, acetylcholine, aminoacids and lactic acid in studies on the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Toxicology, 1988
- Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTPLife Sciences, 1986
- Chronic Use of Intracerebral Dialysis for the In Vivo Measurement of 3,4‐Dihydroxyphenylethylamine and Its Metabolite 3,4‐Dihydroxyphenylacetic AcidJournal of Neurochemistry, 1986
- Amino Acids in Rat Striatal Dialysates: Methodological Aspects and Changes After Electroconvulsive ShockJournal of Neurochemistry, 1985
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridineLife Sciences, 1985
- On the Significance of Endogenous 3‐Methoxytyramine for the Effects of Centrally Acting Drugs on Dopamine Release in the Rat BrainJournal of Neurochemistry, 1982
- Determination of Picomole Amounts of Dopamine, Noradrenaline, 3,4‐Dihydroxyphenylalanine, 3,4‐Dihydroxyphenylacetic Acid, Homovanillic Acid, and 5‐Hydroxyindolacetic Acid in Nervous Tissue After One‐Step Purification on Sephadex G‐10, Using High‐Performance Liquid Chromatography with a Novel Type of Electrochemical DetectionJournal of Neurochemistry, 1981
- Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuronJournal of Pharmacy and Pharmacology, 1976
- Central dopaminergic neurons: Effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acidEuropean Journal of Pharmacology, 1976
- Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activityJournal of Pharmacy and Pharmacology, 1972